Prevenzione primaria della malattia cardiovascolare: c’è bisogno di un’aspirina?
The efficacy of antiplatelet treatment with aspirin in the primary prevention of major cardiovascular events was questioned during 2018, following a new series of trials that we summarize here in a quick synoptic overview. The three studies involved are the ASPREE trial, the ASCEND study and the ARR...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AboutScience Srl
2019-09-01
|
| Seri Bilgileri: | Giornale di Clinica Nefrologia e Dialisi |
| Online Erişim: | https://journals.aboutscience.eu/index.php/gcnd/article/view/535 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|